Vitarka Therapeutics Ltd
Research and experimental development on biotechnology · Sandwich
ActiveUnited KingdomIncorporated 2021Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£461,701
Cash
£480,717
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
—
Equity
£461,701
Average employees
3
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31Company | 2024-12-31Company | 2023-12-31Company | 2022-12-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Net assets | £461,701 | £418,976 | £344,410 | £136,284 | −£10,250 |
| Equity | £461,701 | £418,976 | £344,410 | £136,284 | −£10,250 |
| Assets | |||||
| Current assets | — | — | — | £137,284 | £100 |
| Cash at bank | £480,717 | £403,678 | £357,174 | £129,392 | £100 |
| Liabilities | |||||
| Creditors within one year | — | — | — | £1,000 | £10,350 |
| Net current assets | — | — | — | £136,284 | −£10,250 |
| Assets less current liabilities | — | — | — | £136,284 | −£10,250 |
| Profit & loss | |||||
| Profit / loss | — | — | — | — | −£10,350 |
| People | |||||
| Average employees | 3 | 2 | 2 | 2 | 1 |
| Source evidence | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.